Global NeuroAIDS roundtable

Journal of NeuroVirology

Volumn 19, Issue 1, 2013, Pages 1-9

  Joseph, Jeymohan ^a   Achim, Cristian L ^b   Boivin, Michael J ^c   Brew, Bruce J ^d   Clifford, David B ^e   Colosi, Deborah A ^a   Ellis, Ronald J ^b   Heaton, Robert K ^b   Gallo Diop, Amadou ^f   Grant, Igor ^b   Kanmogne, Georgette D ^g   Kumar, Mahendra ^h   Letendre, Scott ^b   Marcotte, Thomas D ^b   Nath, Avindra ⁱ   Pardo, Carlos A ^j   Paul, Robert H ^k   Pulliam, Lynn ^l   Robertson, Kevin ^m   Royal III, Walter ⁿ   Sacktor, Ned ^j   Sithinamsuwan, Pasiri ^o   Smith, Davey M ^b   Valcour, Victor ^l   Wigdahl, Brian ^p   Wood, Charles ^q   more..

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^g UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^h UNIVERSITY OF MIAMI   (United States)

ⁱ NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF NORTH CAROLINA   (United States)

ⁿ UNIVERSITY OF MARYLAND   (United States)

^o PRAMONGKUTKLAO HOSPITAL   (Thailand)

^p DREXEL UNIVERSITY   (United States)

^q UNIVERSITY OF NEBRASKA LINCOLN   (United States)

more..

Author keywords

Acquired immunodeficiency syndrome (AIDS); HIV clade; HIV associated neurocognitive disorders (HAND); Human immunodeficiency virus type 1 (HIV 1) and type 2 (HIV 2); NeuroAIDS; Neuropathogenesis

Indexed keywords

ATAZANAVIR; CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CD4 LYMPHOCYTE COUNT; DISEASE PREDISPOSITION; EASTERN EUROPE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL SOCIETY; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; NONHUMAN; PHASE 4 CLINICAL TRIAL (TOPIC); PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOUTH AND CENTRAL AMERICA; TROPISM; VIRUS LOAD; VIRUS REPLICATION;

EID: 84873624576     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-012-0143-9     Document Type: Review

References (15)

1. Boivin MJ, Ruel TD, Hannah EB, Bangirana P, Cao H, Eller LA, Charlebois E, Havlir DV, Kamya MR, Achan J, Akello C, Wong JK (2010) HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naïve Ugandan children. AIDS 24:1163-1170
2. Choi Y, Townend J, Vincent T, Zaidi I, Sarge-Njie R, Jaye A, Clifford DB (2011) Neurologic manifestations of human immunodeficiency vius-2: dementia, myelopathy and neuropathy in West Africa. J Neurovirol 2:166-175
3. Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop Valverda D, Ellis R, Ownby R, Subbakrishana DK, Desai A, Ravi V, Rao BS, Satish KS, Kumar M (2007) Neuropsychological deficits in human deficiency virus clade C seropositive adults from South India. J Neurovirol 14:195-202
4. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: Charter Study. Neurology 75:2087-2096
5. Holguin A, Banda M, Willen EJ, Malama C, Chiyenu KO, Mudenda VC, Wood C (2011) HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia. AIDS Behav 8:1895-1901
6. Kamat A, Ravi V, Desai A, Satishchandra P, Satish K, Kumar M (2009) Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease. J Neurovirol 15:25-35
7. Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, Njamnshi DM, Nchindap E, Franklin DR Jr, Ellis RJ, McCutchan JA, Binam F, Mbanya D, Heaton RK, Njamnshi AK (2010) HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 10:60
8. Mahadevan A, Shankar SK, Satishchandra P, Siddappa NB, Udaykumar R, Nath A (2007) HIV-1 subtype C associated neuropathology: is it different? Brain Path 20(Supp 1):81-82
9. Pumpradit W, Ananworanich J, Lolak S, Shikuma C, Paul R, Siangphoe U, Chaoniti N, Kaew-On P, Paris R, Ruxrungtham K, Valcour V (2010) Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol 16:76-82
10. Ranga U, Shankarappa R, Siddapa NB, Ramakrishna L, Nagendran M, Mahalingam M, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR (2004) Tat protein of human immunodeficiency virus type 1 subtype strains is a defective chemokine. J Virol 78:2586-2590
11. Robertson K, Kumwenda K, Supparatpinyo K, Jiang KH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P, AIDS Clinical Trials Group (2011) A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol 5:438-447
12. Royal W 3rd, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchen JA, Grant I, Blattner WA (2012) Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol 18:191-199
13. Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, Musisi S, Katabira E, Ronald A, Clifford DB, Laeyendecker Q, Quinn TC (2009) HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49:780-786
14. Valcour VG, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Ratto-Kim S, Apateerapong W, Shiramizu BT, Desouza MS, Chitpatima ST, Watt G, Chuenchitra T, Robertson KR, Paul RH, McArthur JC, Kim JH, Shikuma CM (2007) Neuropsychological abnormalities in patients with dementia in CRF 01-AE HIV-1 infection. Neurology 68:525-527
15. Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S (2008) Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 71(1):50-56